entertainment -WSS

entertainment

author：leisure time 2025-09-27 10:04:27 - browse：4

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： AltruBio raises $225 million to develop ulcerative colitis drug

Wikipedia

WSS

Chemotherapy before breast cancer surgery might fuel metastasis

Biotech stock slump in 2023: awaiting the turnaround

GSK’s asthma push continues as drug succeeds in Phase 3 trials

AI for drug discovery: Experts on separating hype from reality

CDC's new outbreak response network to include Northeastern

Is it ever OK for doctors to lie to their patients?

focus

entertainment

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Changes to biosimilar regulatory framework must prioritize patients

Hepatitis C has a cure — but many Americans still lack access to it

Warren pushes Witty on UnitedHealth's control over physicians

Walensky prepares to leave CDC — and Congress — behind

GSK’s asthma push continues as drug succeeds in Phase 3 trials

United colonoscopy coverage change 'may cost lives,' doctors say

Primary care doctor shortage won't be solved by free med school tuition

DIEP, the 'gold standard' of breast reconstruction, is under threat

Can gargling with Listerine treat gonorrhea of the mouth?

Wikipedia

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

HHS's proposed rule does nothing to address the climate crisis

Hearing on Medicare drug price negotiation gets unusually heated

As billionaires fund anti

Biotech lab space demand falls sharply

Hearing on Medicare drug price negotiation gets unusually heated

hotspot

Wikipedia

focus

focus